Phytocannabinoide

Unter Phytocannabinoiden versteht man die in der Pflanze Hanf vorkommenden Cannabinoide wie Cannabigerol, Cannabinol, Cannabidiol und Tetrahydrocannabinol, ebenso Tetrahydrocannabivarin und Cannabichromen.

1. Sepulveda DE et al. (2024) The Potential of Cannabichromene (CBC) as a Therapeutic Agent. J Pharmacol Exp Ther. 18;391(2):206-213. doi: 10.1124/jpet.124.002166. PMID: 38777605; PMCID: PMC11493452.
2. Hwang, YN et al. (2025) Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy. Cell Death Discov. 11, 377 (2025). https://doi.org/10.1038/s41420-025-02674-8
3. Kis B et al. (2019) Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer Int J Mol Sci 20: 5905.
4. Nachnani R et al. (2021) The Pharmacological Case for Cannabigerol. Journal of Pharmacology and Experimental Therapeutics February 376: 204-212.
5. Tiwari J et al. (2018) Tetrahydrocannabinol: a drug of interest. Panminerva Med 60:228-230. 
6. Mendoza S. (2025) The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management. AIMS Neurosci.  12;12(1):32-43. doi: 10.3934/Neuroscience.2025003. PMID: 40270953; PMCID: PMC12011981.
7. Abioye A et al. (2020) Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. J Cannabis Res.  31;2(1):6. doi: 10.1186/s42238-020-0016-7. PMID: 33526143; PMCID: PMC7819335.
8. Rahmani N et al (2025) Cannabivarin and Tetrahydrocannabivarin Modulate Nociception via Vanilloid Channels and Cannabinoid-Like Receptors in Caenorhabditis elegans. Can J Physiol Pharmacol. 24. doi: 10.1139/cjpp-2025-0243. Epub ahead of print. PMID: 41135090.